{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:00Z","timestamp":1787022420627,"version":"build-2736575974"},"reference-count":37,"publisher":"Japan Endocrine Society","issue":"9","funder":[{"name":"Foundation for Growth Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej25-0047","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T18:07:41Z","timestamp":1749146861000},"page":"1041-1049","source":"Crossref","is-referenced-by-count":3,"title":["Body mass index and metabolic complications in individuals with treatment-na\u00efve acromegaly"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4084-9655","authenticated-orcid":false,"given":"Naoki","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-232X","authenticated-orcid":false,"given":"Shin","family":"Urai","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-8134","authenticated-orcid":false,"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"},{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-2714","authenticated-orcid":false,"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Motomura","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ohmachi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Oi-Yo","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"},{"name":"Department of Nutrition, Kobe University Hospital, Kobe, 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"},{"name":"Faculty of Clinical Nutrition and Dietetics, Department of Clinical Nutrition and Dietetics, Konan Women\u2019s University, Kobe 658-0001, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Hospital, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Boutari C, Mantzoros CS (2022) A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism 133: 155217.","DOI":"10.1016\/j.metabol.2022.155217"},{"key":"2","unstructured":"2 (2024) Obesity and overweight. World Health Organization. Regional Office for Europe. Copenhagen, Denmark. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight accessed on July 10, 2024."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, et al. (2005) Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 94: 1\u201312.","DOI":"10.1159\/000088200"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 (2002) New criteria for \u2018obesity disease\u2019 in Japan. Circ J 66: 987\u2013992.","DOI":"10.1253\/circj.66.987"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Conway B, Rene A (2004) Obesity as a disease: no lightweight matter. Obes Rev 5: 145\u2013151.","DOI":"10.1111\/j.1467-789X.2004.00144.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ogawa W, Hirota Y, Miyazaki S, Nakamura T, Ogawa Y, et al. (2024) Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J 71: 223\u2013231.","DOI":"10.1507\/endocrj.EJ23-0593"},{"key":"7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"G Whitlock","year":"2009","unstructured":"7 Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. (2009) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083\u20131096.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93: 61\u201367.","DOI":"10.1210\/jc.2007-1191"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40: 268\u2013332.","DOI":"10.1210\/er.2018-00115"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kineman RD, Del Rio-Moreno M, Sarmento-Cabral A (2018) 40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1\/IGF1R in regulating metabolism using the Cre\/loxP system. J Mol Endocrinol 61: T187\u2013T198.","DOI":"10.1530\/JME-18-0076"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Freda PU (2022) The acromegaly lipodystrophy. Front Endocrinol (Lausanne) 13: 933039.","DOI":"10.3389\/fendo.2022.933039"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, et al. (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99: 3933\u20133951.","DOI":"10.1210\/jc.2014-2700"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sasaki A, Yokote K, Naitoh T, Fujikura J, Hayashi K, et al. (2022) Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity. Diabetol Int 13: 1\u201330.","DOI":"10.1007\/s13340-021-00551-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Araki E, Goto A, Kondo T, Noda M, Noto H, et al. (2020) Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig 11: 1020\u20131076.","DOI":"10.1111\/jdi.13306"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, et al. (2018) Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25: 846\u2013984.","DOI":"10.5551\/jat.GL2017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Umemura S, Arima H, Arima S, Asayama K, Dohi Y, et al. (2019) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yamanaka H (2011) Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 30: 1018\u20131029.","DOI":"10.1080\/15257770.2011.596496"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, et al. (2012) Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 18: 1508\u20131516.","DOI":"10.3748\/wjg.v18.i13.1508"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, et al. (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13: 479\u2013504.","DOI":"10.5664\/jcsm.6506"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 (2024) EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81: 492\u2013542.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-J\u00e4rvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295\u2013301.","DOI":"10.2337\/diacare.23.3.295"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22 Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55: 1430\u20131435.","DOI":"10.2337\/db05-1200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, et al. (2016) Hormonal replacement in hypopituitarism in adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 3888\u20133921.","DOI":"10.1210\/jc.2016-2118"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, et al. (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59: 771\u2013780.","DOI":"10.1507\/endocrj.EJ12-0110"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Matsubayashi K, Kawakami K (2020) Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database. Endocr J 67: 997\u20131006.","DOI":"10.1507\/endocrj.EJ20-0129"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, et al. (2019) Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 7: 715\u2013725.","DOI":"10.1016\/S2213-8587(19)30084-1"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27 Katznelson L (2009) Alterations in body composition in acromegaly. Pituitary 12: 136\u2013142.","DOI":"10.1007\/s11102-008-0104-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Dichtel LE, Corey KE, Haines MS, Chicote ML, Kimball A, et al. (2022) The GH\/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight\/obesity. J Clin Endocrinol Metab 107: e3624\u2013e3632.","DOI":"10.1210\/clinem\/dgac405"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Dichtel LE, Corey KE, Haines MS, Chicote ML, Lee H, et al. (2023) Growth hormone administration improves nonalcoholic fatty liver disease in overweight\/obesity: a randomized trial. J Clin Endocrinol Metab 108: e1542\u2013e1550.","DOI":"10.1210\/clinem\/dgad375"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Dichtel LE, Cordoba-Chacon J, Kineman RD (2022) Growth hormone and insulin-like growth factor 1 regulation of nonalcoholic fatty liver disease. J Clin Endocrinol Metab 107: 1812\u20131824.","DOI":"10.1210\/clinem\/dgac088"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, et al. (2021) The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995\u20132040. Hepatol Int 15: 366\u2013379.","DOI":"10.1007\/s12072-021-10143-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Vancells Lujan P, Vi\u00f1as Esmel E, Sacanella Meseguer E (2021) Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients 13: 1442.","DOI":"10.3390\/nu13051442"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ero\u011flu \u0130, Iremli BG, Idilman IS, Yuce D, Lay I, et al. (2023) Nonalcoholic fatty liver disease, liver fibrosis, and utility of noninvasive scores in patients with acromegaly. J Clin Endocrinol Metab 109: e119\u2013e129.","DOI":"10.1210\/clinem\/dgad490"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Schneider HJ, Saller B, Klotsche J, M\u00e4rz W, Erwa W, et al. (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 154: 699\u2013706.","DOI":"10.1530\/eje.1.02131"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Khiyami A, Mehrotra N, Venugopal S, Mahmud H, Zenonos GA, et al. (2023) IGF-1 is positively associated with BMI in patients with acromegaly. Pituitary 26: 221\u2013226.","DOI":"10.1007\/s11102-023-01307-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Deurenberg P, Deurenberg-Yap M, Guricci S (2002) Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship. Obes Rev 3: 141\u2013146.","DOI":"10.1046\/j.1467-789X.2002.00065.x"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37 Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, et al. (2013) Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 36: 1789\u20131796.","DOI":"10.2337\/dc12-1235"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:33:31Z","timestamp":1757129611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/9\/72_EJ25-0047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0047","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ25-0047"}}